Valsartan Special Master Won’t Exclude Expert Who Cited AI-Generated Sources

( September 15, 2025, 10:32 AM EDT) -- CAMDEN, N.J. — The special master in the valsartan, XE "valsartan"  losartan and XE "losartan"  irbesartan XE "irbesartan"  hypertension drugs multidistrict litigation pending in a New Jersey federal court denied a motion to exclude an expert retained by a bellwether plaintiff, finding that the expert’s citation to nonexistent sources due to his use of artificial intelligence did not warrant exclusion....

Attached Documents

Related Sections